Azitra Inc
AZTR0.318USD
+0.020+6.90%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
1.78MMarket Cap
LossP/E TTM
More Details of Azitra Inc Company
Azitra, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing advanced therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. It has built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its lead product, ATR-12, is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its advanced product, ATR-04, is a genetically modified strain of S. epidermidis for treating papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.
Azitra Inc Info
Ticker SymbolAZTR
Company nameAzitra Inc
IPO dateJun 16, 2023
CEOSalva (Francisco D)
Number of employees12
Security typeOrdinary Share
Fiscal year-endJun 16
Address21 Business Park Drive, Suite 6
CityBRANFORD
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code06405
Phone12034890183
Websitehttps://azitrainc.com/
Ticker SymbolAZTR
IPO dateJun 16, 2023
CEOSalva (Francisco D)
Company Executives of Azitra Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Francisco D. Salva
Mr. Francisco D. Salva
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.77K
+4.61%
Mr. John R. Schroer
Mr. John R. Schroer
Independent Director
Independent Director
2.00
--
Ms. Barbara Ryan
Ms. Barbara Ryan
Independent Director
Independent Director
--
--
Mr. Travis M. Whitfill
Mr. Travis M. Whitfill
Co-Founder, Chief Operating Officer, Director
Co-Founder, Chief Operating Officer, Director
--
--
Mr. Norman Staskey
Mr. Norman Staskey
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Francisco D. Salva
Mr. Francisco D. Salva
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.77K
+4.61%
Mr. John R. Schroer
Mr. John R. Schroer
Independent Director
Independent Director
2.00
--
Ms. Barbara Ryan
Ms. Barbara Ryan
Independent Director
Independent Director
--
--
Mr. Travis M. Whitfill
Mr. Travis M. Whitfill
Co-Founder, Chief Operating Officer, Director
Co-Founder, Chief Operating Officer, Director
--
--
Mr. Norman Staskey
Mr. Norman Staskey
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Dec 22
Updated: Mon, Dec 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alumni Capital LP
4.99%
Geode Capital Management, L.L.C.
0.20%
National Bank of Canada
0.18%
Bayer HealthCare LLC
0.07%
Salva (Francisco D)
0.02%
Other
94.54%
Shareholders
Shareholders
Proportion
Alumni Capital LP
4.99%
Geode Capital Management, L.L.C.
0.20%
National Bank of Canada
0.18%
Bayer HealthCare LLC
0.07%
Salva (Francisco D)
0.02%
Other
94.54%
Shareholder Types
Shareholders
Proportion
Corporation
5.06%
Investment Advisor/Hedge Fund
0.20%
Bank and Trust
0.18%
Individual Investor
0.05%
Other
94.51%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
22
42.28K
3.33%
--
2025Q3
23
42.28K
10.13%
-246.57K
2025Q2
26
349.24K
8.85%
-19.67K
2025Q1
26
368.91K
8.01%
+188.81K
2024Q4
24
133.27K
21.59%
+17.83K
2024Q3
23
115.45K
19.94%
-107.27K
2024Q2
20
40.40K
859.30%
-4.76K
2024Q1
18
45.16K
23.54%
+11.22K
2023Q4
11
33.82K
1.57%
-425.00
2023Q3
10
34.25K
1.12%
+271.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Geode Capital Management, L.L.C.
21.76K
0.62%
+719.00
+3.42%
Jun 30, 2025
National Bank of Canada
19.52K
0.55%
+3.00K
+18.18%
Jun 30, 2025
Bayer HealthCare LLC
7.26K
0.21%
+712.00
+10.88%
Sep 30, 2024
Salva (Francisco D)
1.77K
0.05%
+78.00
+4.61%
May 28, 2025
Whitfill (Travis)
1.68K
0.05%
+2.00
+0.12%
May 28, 2025
UBS Financial Services, Inc.
16.49K
0.47%
-9.56K
-36.71%
Jun 30, 2025
Fletcher (Aaron G.L.)
811.00
0.02%
--
--
Jul 30, 2024
Kreis (Leslie W JR)
456.00
0.01%
--
--
Jul 30, 2024
Staskey (Norm)
258.00
0.01%
+2.00
+0.78%
May 28, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 11, 2025
Merger
6.66→1
Jun 03, 2024
Merger
30→1
Jun 03, 2024
Merger
30→1
Jun 03, 2024
Merger
30→1
Jun 03, 2024
Merger
30→1
Date
Type
Ratio
Aug 11, 2025
Merger
6.66→1
Jun 03, 2024
Merger
30→1
Jun 03, 2024
Merger
30→1
Jun 03, 2024
Merger
30→1
Jun 03, 2024
Merger
30→1
FAQs
Who are the top five shareholders of Azitra Inc?
The top five shareholders of Azitra Inc are:
Geode Capital Management, L.L.C. holds 21.76K shares, accounting for 0.62% of the total shares.
National Bank of Canada holds 19.52K shares, accounting for 0.55% of the total shares.
Bayer HealthCare LLC holds 7.26K shares, accounting for 0.21% of the total shares.
Salva (Francisco D) holds 1.77K shares, accounting for 0.05% of the total shares.
Whitfill (Travis) holds 1.68K shares, accounting for 0.05% of the total shares.
Geode Capital Management, L.L.C. holds 21.76K shares, accounting for 0.62% of the total shares.
National Bank of Canada holds 19.52K shares, accounting for 0.55% of the total shares.
Bayer HealthCare LLC holds 7.26K shares, accounting for 0.21% of the total shares.
Salva (Francisco D) holds 1.77K shares, accounting for 0.05% of the total shares.
Whitfill (Travis) holds 1.68K shares, accounting for 0.05% of the total shares.
What are the top three shareholder types of Azitra Inc?
The top three shareholder types of Azitra Inc are:
Alumni Capital LP
Geode Capital Management, L.L.C.
National Bank of Canada
Alumni Capital LP
Geode Capital Management, L.L.C.
National Bank of Canada
How many institutions hold shares of Azitra Inc (AZTR)?
As of 2025Q4, 22 institutions hold shares of Azitra Inc, with a combined market value of approximately 42.28K, accounting for 3.33% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -6.81%.
What is the biggest source of revenue for Azitra Inc?
In --, the -- business generated the highest revenue for Azitra Inc, amounting to -- and accounting for --% of total revenue.
